Skip to content
1887

Abstract

The National Tuberculosis Programme (NTBP) monitors the occurrence and spread of tuberculosis (TB) and multidrug-resistant TB (MDR-TB) in Singapore. Since 2020, whole-genome sequencing (WGS) of isolates has been performed at the National Public Health Laboratory (NPHL) for genomic surveillance, replacing spoligotyping and mycobacterial interspersed repetitive unit-variable number tandem repeats analysis (MIRU-VNTR). Four thousand three hundred and seven samples were sequenced from 2014 to January 2023, initially as research projects and later developed into a comprehensive public health surveillance programme. Currently, all newly diagnosed culture-positive cases of TB in Singapore are prospectively sent for WGS, which is used to perform lineage classification, predict drug resistance profiles and infer genetic relationships between TB isolates. This paper describes NPHL’s operational and technical experiences with implementing the WGS service in an urban TB-endemic setting, focusing on cluster detection and genomic drug susceptibility testing (DST). Cluster detection: WGS has been used to guide contact tracing by detecting clusters and discovering unknown transmission networks. Examples have been clusters in a daycare centre, housing apartment blocks and a horse-racing betting centre. Genomic DST: genomic DST prediction (gDST) identifies mutations in core genes known to be associated with TB drug resistance catalogued in the TBProfiler drug resistance mutation database. Mutations are reported with confidence scores according to a standardized approach referencing NPHL’s internal gDST confidence database, which is adapted from the World Health Organization (WHO) TB drug mutation catalogue. Phenotypic–genomic concordance was observed for the first-line drugs ranging from 2959/2998 (98.7 %) (ethambutol) to 2983/2996 (99.6 %) (rifampicin). Aspects of internal database management, reporting standards and caveats in results interpretation are discussed.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001139
2023-11-27
2025-01-17
Loading full text...

Full text loading...

/deliver/fulltext/mgen/9/11/mgen001139.html?itemId=/content/journal/mgen/10.1099/mgen.0.001139&mimeType=html&fmt=ahah

References

  1. Loh KS, Hsu LY. Tuberculosis in Singapore: past and future. Ann Acad Med Singap 2019; 48:72–74 [View Article]
    [Google Scholar]
  2. Yap P, Tan KHX, Lim WY, Barkham T, Tan LWL et al. Prevalence of and risk factors associated with latent tuberculosis in Singapore: a cross-sectional survey. Int J Infect Dis 2018; 72:55–62 [View Article] [PubMed]
    [Google Scholar]
  3. Lim VW, Wee HL, Lee P, Lin Y, Tan YR et al. Cross-sectional study of prevalence and risk factors, and a cost-effectiveness evaluation of screening and preventive treatment strategies for latent tuberculosis among migrants in Singapore. BMJ Open 2021; 11:e050629 [View Article] [PubMed]
    [Google Scholar]
  4. Ministry of Health Singapore Prevention, Diagnosis and Management of Tuberculosis: MOH Clinical Practice Guidelines. Retrieved from Ministry of Health Singapore; 2016 https://www.moh.gov.sg/docs/librariesprovider4/guidelines/moh-tb-cpg-full-version-for-website.pdf
  5. Chee CBE, Hsu L-Y, Sng L-H, Leo Y-S, Cutter J et al. MDR TB transmission, Singapore. Emerg Infect Dis 2013; 19:1151–1152 [View Article] [PubMed]
    [Google Scholar]
  6. Chee CBE, Khin-Mar Kyi Win, Cutter Jeffery, Wang Yee Tang. The imminent threat of multidrug-resistant tuberculosis in Singapore. Singapore Med J 2012; 53:238–239
    [Google Scholar]
  7. Chee CBE, Gan S-H, Ong RT, Sng L-H, Wong CW et al. Multidrug-resistant tuberculosis outbreak in gaming centers, Singapore, 2012. Emerg Infect Dis 2015; 21:179–180 [View Article] [PubMed]
    [Google Scholar]
  8. Ho ZJM, Chee CBE, Ong RT-H, Sng LH, Peh WLJ et al. Investigation of a cluster of multi-drug resistant tuberculosis in a high-rise apartment block in Singapore. Int J Infect Dis 2018; 67:46–51 [View Article] [PubMed]
    [Google Scholar]
  9. Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol 2019; 17:533–545 [View Article] [PubMed]
    [Google Scholar]
  10. Reyes JF, Chan CHS, Tanaka MM. Impact of homoplasy on variable numbers of tandem repeats and spoligotypes in Mycobacterium tuberculosis. Infect Genet Evol 2012; 12:811–818 [View Article] [PubMed]
    [Google Scholar]
  11. Reddy TBK, Riley R, Wymore F, Montgomery P, DeCaprio D et al. TB database: an integrated platform for tuberculosis research. Nucleic Acids Res 2009; 37:D499–508 [View Article] [PubMed]
    [Google Scholar]
  12. Chee CBE, Lim LKY, Ong RTH, Sng LH, Hsu LY et al. Whole genome sequencing analysis of multidrug-resistant tuberculosis in Singapore, 2006–2018. Eur J Clin Microbiol Infect Dis 2021; 40:1079–1083 [View Article]
    [Google Scholar]
  13. Kam MLW, Lim LKY, Sng L-H, Ong RT-H, Lee VJM et al. Country-wide genotyping of Mycobacterium tuberculosis complex in Singapore, 2011–2017. Tuberculosis 2022; 134:102204 [View Article]
    [Google Scholar]
  14. Phelan JE, O’Sullivan DM, Machado D, Ramos J, Oppong YEA et al. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs. Genome Med 2019; 11:41 [View Article] [PubMed]
    [Google Scholar]
  15. Phelan J. TBDB: A repository for the TBProfiler library; 2022 https://github.com/jodyphelan/tbdb accessed 28 October 2022
  16. Kohl TA, Utpatel C, Schleusener V, De Filippo MR, Beckert P et al. MTBseq: a comprehensive pipeline for whole genome sequence analysis of Mycobacterium tuberculosis complex isolates. PeerJ 2018; 6:e5895 [View Article] [PubMed]
    [Google Scholar]
  17. Rausch T, Zichner T, Schlattl A, Stütz AM, Benes V et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 2012; 28:i333–i339 [View Article] [PubMed]
    [Google Scholar]
  18. Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J 2017; 50:1701354 [View Article] [PubMed]
    [Google Scholar]
  19. Stucki D, Ballif M, Egger M, Furrer H, Altpeter E et al. Standard genotyping overestimates transmission of Mycobacterium tuberculosis among immigrants in a low-incidence country. J Clin Microbiol 2016; 54:1862–1870 [View Article] [PubMed]
    [Google Scholar]
  20. Lim LK-Y, Sng LH, Win W, Chee CB-E, Hsu LY et al. Molecular epidemiology of Mycobacterium tuberculosis complex in Singapore, 2006-2012. PLoS One 2013; 8:e84487 [View Article]
    [Google Scholar]
  21. Hanekom M, van der Spuy GD, Gey van Pittius NC, McEvoy CRE, Hoek KGP et al. Discordance between mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing and IS6110 restriction fragment length polymorphism genotyping for analysis of Mycobacterium tuberculosis Beijing strains in a setting of high incidence of tuberculosis. J Clin Microbiol 2008; 46:3338–3345 [View Article] [PubMed]
    [Google Scholar]
  22. Ministry of Health Singapore Precautionary Tuberculosis Screening for Patrons of Singapore Pools Bedok Betting Centre. Retrieved from Ministry of Health News Highlights; 2021 https://www.moh.gov.sg/news-highlights/details/precautionary-tuberculosis-screening-for-patrons-of-singapore-pools-bedok-betting-centre
  23. Ford CB, Lin PL, Chase MR, Shah RR, Iartchouk O et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet 2011; 43:482–486 [View Article] [PubMed]
    [Google Scholar]
  24. Comín J, Cebollada A. Aragonese Working Group on Molecular Epidemiology of Tuberculosis (EPIMOLA) Samper S. Estimation of the mutation rate of Mycobacterium tuberculosis in cases with recurrent tuberculosis using whole genome sequencing. Sci Rep 2022; 12:16728 [View Article] [PubMed]
    [Google Scholar]
  25. Cohen KA, Manson AL, Desjardins CA, Abeel T, Earl AM. Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges. Genome Med 2019; 11:45 [View Article] [PubMed]
    [Google Scholar]
  26. Dale K, Globan M, Horan K, Sherry N, Ballard S et al. Whole genome sequencing for tuberculosis in Victoria, Australia: a genomic implementation study from 2017 to 2020. Lancet Reg Health West Pac 2022; 28:100556 [View Article] [PubMed]
    [Google Scholar]
  27. Lalor MK, Casali N, Walker TM, Anderson LF, Davidson JA et al. The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak. Eur Respir J 2018; 51:1702313 [View Article] [PubMed]
    [Google Scholar]
  28. Walker TM, Ip CLC, Harrell RH, Evans JT, Kapatai G et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 2013; 13:137–146 [View Article] [PubMed]
    [Google Scholar]
  29. Tagliani E, Anthony R, Kohl TA, de Neeling A, Nikolayevskyy V et al. Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017-2019: an ECDC pilot study. Eur Respir J 2021; 57:2002272 [View Article] [PubMed]
    [Google Scholar]
  30. Mok S, Roycroft E, Flanagan PR, Montgomery L, Borroni E et al. Overcoming the challenges of pyrazinamide susceptibility testing in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2021; 65:e0261720 [View Article]
    [Google Scholar]
  31. Park M, Lalvani A, Satta G, Kon OM. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance. BMC Infect Dis 2022; 22:349 [View Article] [PubMed]
    [Google Scholar]
  32. Cabibbe AM, Trovato A, De Filippo MR, Ghodousi A, Rindi L et al. Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries. Eur Respir J 2018; 51:1800387 [View Article] [PubMed]
    [Google Scholar]
  33. Vogel M, Utpatel C, Corbett C, Kohl TA, Iskakova A et al. Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country. Sci Rep 2021; 11:15333 [View Article] [PubMed]
    [Google Scholar]
  34. Kizny Gordon A, Marais B, Walker TM, Sintchenko V. Clinical and public health utility of Mycobacterium tuberculosis whole genome sequencing. Int J Infect Dis 2021; 113 Suppl 1:S40–S42 [View Article] [PubMed]
    [Google Scholar]
  35. van der Werf MJ, Ködmön C. Whole-genome sequencing as tool for investigating international tuberculosis outbreaks: a systematic review. Front Public Health 2019; 7:87 [View Article] [PubMed]
    [Google Scholar]
  36. Quick J. nCoV-2019 Sequencing Protocol V1 2020 [View Article]
    [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001139
Loading
/content/journal/mgen/10.1099/mgen.0.001139
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Supplementary material 3

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error